[1]
|
Oh H,Takagi H,Otani A,et al.Selective induction of neuropilin-1 by vascular endothelial growth factor:a mechanism contributing to VEGF-induced angilgenesis[J].PNAS,2002,99(1):383-388. |
[2] Imura S,Miyake H,Izumi K,et al.Correlation of vascular endothelial cell proliferation with microvessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in hepatocellular carcinoma[J].Med Invest,2004,51(34):202-209. |
[3] Hayashibara T,Yamada Y,Miyanishi T,et al.Vascular endothelial growth factor and cellular chemotaxis:a possible autocrine pathway in adult T-cell leukemia cell invasion[J].Clin Cancer Res,2001,7(9):2719-2726. |
[4] 张金巧,王金铠,李英敏,等.急性髓系白血病患者治疗前后血管内皮生长因子及其受体的变化[J].中华血液学杂志,2004,25(2):100-102. |
[5] 叶琇锦,王丽君,林茂芳,等.急性白血病患者骨髓血管新生的研究及临床意义[J].中华内科杂志,2003,42(3):486-488. |
[6] de Bont ES,Rosati S,Jacobs S,et al.Increased bone marrow vascularization in patients with acute myeloid leukemia:a possible role for vascular endothelial growth factor[J].Br J Haematol,2001,113(2):296-304. |
[7] Aguayo A,Kantarjian HM,Estey EH,et al.Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes[J].Cancer,2002,95(9):1923-1930. |
[8] 方莉莉.VEGF对耐药白血病细胞生物学特性的影响[D].硕士学位论文,2009. |
[9] Mayerhofer M,Valent P,Sperr WR,et al.BCR/ABL induces expression of vascular endothelial grouth factor and its transcriptional activator hypoxia inducible factor-1,through a pathway involving phosphoinositide 3-Kinase and the mammalian target of rapamycin[J].Blood,2002,100(10):3767-3775. |
[10] Ben Arush MW,Ben Barak A,Maurice S,et al.Serum VEGF as a significant marker of treatment response in Hodgkin lymphoma[J].Pediatr Hematol Oncol,2007,24(2):11l-115. |
[11] 龚凡杰.环氧化酶-2及血管内皮生长因子在慢性粒细胞性白血病中的表达特点和意义研究[D].博士学位论文,2007. |
[12] Vacca A,Ria R,Ribatti D,et al.A paracrine loop in the vascular endothelial growth factor pathway triggers tumor anglogenesis and growth in multiple myeloma[J].Haematologica,2003,88(2):176-185. |
[13] Suvannasankha A,Fausel C,Juliar BE.et al.Final report of toxicity and efficacy of a phase II study of oral cyclophosphamide,thalidomide,and prednisone for patients with relapsed or refractory multiple myeloma:A Hoosier Oncology Group Trial HEM01-21[J].Oncologist,2007,12(1):99-106. |
[14] 周慷,邓建川,娄世锋,等.多发性骨髓瘤 survivin与VEGF表达的相关性及临床意义[J].肿瘤防治研究,2009,36(7):593-595. |
[15] 包红雨,朱明清,江淼,等.VEGF与COX-2在多发性骨髓瘤病人中的表达及意义[J].中国实验血液学杂志,2009,17(1):99-101. |
[16] 宋强,张茂宏,李丽珍,等.骨髓增生异常综合征及急性髓系白血病患者血清中血管内皮生长因子水平的检测[J].中华血液学杂志,2004,25(1):46-47. |
[17] Alison S,Iannone M,Lisa R,et al.Expression of VEGF,VEGF receptors,and other angiogenic markers in relapsed aggressive non-Hodgkins lymphoma[J].Am Soci Hematol,2004,104(6):109-113. |
[18] 丁琪,廖小海,郑素萍.血管内皮生长因子与血液系统恶性疾病的相关性研究[J].现代临床医学,2007,33(A01):23-25. |
[19] 宋强,张茂宏,李丽珍,等.骨髓增生异常综合征及急性髓细胞白血病患者血清中VEGF水平的检测[J].中华血液学杂志,2004,25(1):46-47. |